Clarendon Partnership Funding
Scholars attending the Welcome Event
Credit: Evan Hann, DPhil Medical Sciences (Clarendon Scholar)

Partnership Awards

Clarendon has many valued partners throughout Oxford and beyond, who through their generous support, enable us to fund as many as 40 additional scholarships each year.

The Clarendon Fund works in collaboration with a range of other funders, including colleges, academic departments and divisions, University trust funds, and external organisations whose generous contributions help fund additional scholarships by allowing us to spread the costs between multiple sources. For the 2024-25 cohort Clarendon is collaborating with over 250 partnership awards providing an additional £9.1m to support new scholars. Every year, the majority of Clarendon scholars are funded by Clarendon and one or more of our partners. In the 2023-24 cohort 57% of scholars received college partnership awards worth to over £3.16m all together.

After acceptance of a Clarendon scholarship, the process of creating tailored funding packages begins. The Clarendon Fund Administrator will review and match new scholars with suitable partnership awards depending on eligibility requirements. No further information will be required of candidates in order to be considered for these awards. Some scholars may need to transfer colleges in order to take up a partnership award, however this will be handled by the Clarendon Fund Administrator by liaising with the colleges as required.

During this period, the scholarship is secure and we guarantee that the total value of the award will not decrease as a result of the inclusion of any partnership awards. The majority of scholars will receive some form of partnership funding and most will have a funding package unique to them. Awards comprising partnership funding are also co-named, to recognise the partner's contribution. Once the funding package is confirmed, applicants will be sent a Clarendon funding breakdown letter (aka a'CB2') outlining the funding arrangements.

Was this page useful?*